ALNY vs IBKR · P/E 76, rev $1.29B vs P/E 36, rev $1.46B
Alnylam Pharmaceuticals Inc (ALNY) versus Interactive Brokers Group Inc (IBKR) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Interactive Brokers Group Inc (IBKR) is a capital markets company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported IBKR revenue for 2026-06-30 was $1.46B. Net income was $2.51B. IBKR currently screens at market cap $143.16B and trailing P/E 36.2.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. IBKR currently screens at market cap $143.16B and trailing P/E 36.2.
Not investment advice. Open the ALNY and IBKR stock pages for the full models.
Not investment advice.